Contraindicated in:
Use Cautiously in:
CV: QT INTERVAL PROLONGATION, VENTRICULAR ARRHYTHMIAS, atrial fibrillation, bradycardia, chest pain, peripheral edema, tachycardia.
Derm: rash, alopecia.
F and E: hyperkalemia, hypokalemia, hypomagnesemia, hyponatremia.
GI: abdominal pain, constipation, diarrhea, hyperbilirubinemia, ↑liver enzymes, metallic taste, mucositis, nausea, vomiting.
GU: ↓fertility (males), renal impairment.
Hemat: hemorrhage, anemia, neutropenia, thrombocytopenia.
MS: ↑creatine kinase, muscle spasm, pain.
Neuro: dizziness, fatigue, headache.
Resp: cough, dyspnea, pneumonia.
Misc: fever.
Drug-Drug:
Therapeutic Classification: antineoplastics
Pharmacologic Classification: hedgehog pathway inhibitors
Absorption: 77% absorbed following oral administration; reduced by high-fat, high calorie foods.
Distribution: Extensively distributed to tissues.
Protein Binding: 91%.
Metabolism/Excretion: Mostly metabolized in the liver by the CYP3A4 isoenzyme, and to some extent by CYP2C8 and UGT1A9. 42% excreted in urine (20% as unchanged drug), 42% excreted in feces (20% as unchanged drug).
Half-life: 17.4 hr.
NDC Code*